Contact Levi & Korsinsky by March 4, 2025 Deadline to Join Class Action Against Revance Therapeutics, Inc. (RVNC)
Portfolio Pulse from
Levi & Korsinsky, LLP has announced a class action securities lawsuit against Revance Therapeutics, Inc. (NASDAQ: RVNC). Investors have until March 4, 2025, to join the lawsuit.
March 04, 2025 | 5:30 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Revance Therapeutics is facing a class action securities lawsuit, with a deadline for investors to join by March 4, 2025.
The announcement of a class action lawsuit against Revance Therapeutics is likely to negatively impact its stock price in the short term due to potential legal liabilities and investor concerns.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100